Rasagiline Tablet
Product Images NDC 13668-447

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 13668-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.5-mg (0.5mg)

Each uncoated tablet contains 0.5 mg rasagiline (equivalent to 0.78 g rasagiline mesylate). This medication should be kept away from children and stored at a temperature between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is recommended to dispense in a tight container with a child-resistant closure. This medication information is intended for prescription use only.*

FDA Label Image

1-mg (1mg)

This text provides information about a medication called Rasagiline in tablet form. Each tablet contains 1 gram of Rasagiline and is equivalent to 1.56 mg of Rasagiline mesylate. The tablets should be kept out of the reach of children and stored at 20° to 25°C with excursions permitted between 15° to 30°C. The usual dosage instructions are not provided, and further prescribing information is recommended. The tablets should be dispensed in a tight container with a child-resistant closure. The manufacturing information indicates that the medication is produced by Torrent Pharmaceuticals LTD in India for Torrent Pharma INC. in Basking Ridge, New Jersey.*

FDA Label Image

Logo (Logo)

FDA Label Image

Image (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.